<PAGE> 1
FORM 8 - A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
MEDICIS PHARMACEUTICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 52-1574808
(State of incorporation or organization) (I.R.S. Employer Identification No.)
4343 East Camelback Road, Suite 250, Phoenix, Arizona 85018-2700
(Address of principal executive offices) (Zip Code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. /X/
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box. / /
Securities Act registration statement file number to which this form relates (if
applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
Class A Common Stock, $0.014 Par Value New York Stock Exchange
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered
The capital stock of Medicis Pharmaceutical Corporation (the
"Registrant") to be registered on the New York Stock Exchange, Inc. (the
"Exchange"), is the Registrant's Class A Common Stock with a par value of $0.014
per share. A description of the Registrant's Class A Common Stock is contained
in the Registrant's Registration Statement on Form S-3 (Registration No.
333-44053) as filed with the SEC on January 12, 1998 and is incorporated herein
by reference.
Item 2. Exhibits
All exhibits required by Instruction II to Item 2 will be supplied to
the New York Stock Exchange.
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized.
MEDICIS PHARMACEUTICAL CORPORATION
By: /s/ Jonah Shacknai
--------------------------------------------
Jonah Shacknai
Chairman and Chief Executive Officer
Dated: September 17, 1998.
2
